Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

VIBES Integrating virology, artificial intelligence and biophotonics for innovative antiviral strategies against emerging flaviviruses

Coordinator
Leibniz-Institut Fuer Photonische Technologien E.v., Germany
Runs
1 January 2027 to 31 December 2030
Status
Running
EU funding
€4.1m
Total cost
—
Partners
24 organisations in 8 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101312032

What the project is doing

In the project's own words, from its summary on CORDIS.

Emerging viral diseases pose a growing threat to global health. Orthoflaviviruses, including dengue, West Nile, and Zika viruses, are of particular concern due to their significant disease burden, complex transmission dynamics and lack of effective interventions. A combination of multiple global changes has already led to increased dengue and West Nile fever incidence in Europe, highlighting the urgent need for innovative approaches to combat these emerging health threats.

VIBES responds to this need with unique interdisciplinary consortium that brings together the rapidly evolving fields of virology, biophotonics, bioinformatics and artificial intelligence, to develop advanced tools and approaches for characterizing host-pathogen interactions and identifying novel antiviral strategies. International partners (including 6 non-academic) from eight countries unite to foster sustainable academic and industrial collaboration.

VIBES will train fourteen doctoral candidates (DCs) in interdisciplinary research aimed at unraveling viral molecular pathomechanisms, identifying and validating new antiviral targets and drugs, and developing innovative bioinformatic tools and powerful biophotonic methods. Each DC will gain hands-on experience in cutting-edge biophotonics, bioinformatics and virology, leveraging complementary tools to drive the project’s scientific objectives.

Individual projects will encompass molecular characterization, target discovery and drug development, in vitro and in vivo validation, and development of cutting-edge antiviral technologies. The network emphasizes high-quality training, career development, and interdisciplinary supervision, equipping the next generation of scientists with the skills to address pressing global health challenges. By bridging academic and industrial expertise in a highly trans-disciplinary approach, VIBES strengthens Europe’s research and innovation capacity, paving the way for impactful solutions to emerging viral threats.

Who is involved

OrganisationCityCountryRole
Leibniz-Institut Fuer Photonische Technologien E.v.JenaGermanyCoordinator
Ustav Fotoniky a Elektroniky Av Cr V.v.i.Praha 8CzechiaParticipant
Vysoka Skola Chemicko-Technologicka V PrazePrahaCzechiaAssociatedpartner
Bundesinstitut Fur Impfstoffe Und Biomedizinische ArzneimittelLangenGermanyAssociatedpartner
Chemometrix GmbHWolfersheimGermanyParticipant
Friedrich-Schiller-Universität JenaJenaGermanyAssociatedpartner
InfectoGnostics Forschungscampus Jena e.V.JenaGermanyAssociatedpartner
Johann Wolfgang Goethe-Universitaet Frankfurt Am MainFrankfurt Am MainGermanyAssociatedpartner
Leibniz-Institut Fur VirologieHamburgGermanyParticipant
Universitatsklinikum JenaJenaGermanyParticipant
University of HamburgHamburgGermanyAssociatedpartner
openUC2 GmbHJenaGermanyAssociatedpartner
Institut De Recherche Pour Le DeveloppementMarseilleFranceParticipant
Institut PasteurParisFranceParticipant
Universite De MontpellierMontpellierFranceAssociatedpartner
Universite Paris CiteParisFranceAssociatedpartner
UrbilateriaSaint Cyr sur LoireFranceAssociatedpartner
Institut Pasteur Du CambodgePhnom PenhKHAssociatedpartner
Universidad Peruana De Ciencias Aplicadas SacLimaPEParticipant
Bmd Software LdaAveiroPortugalParticipant
Universidade De AveiroAveiroPortugalAssociatedpartner
Universidade De CoimbraCoimbraPortugalParticipant
Karolinska InstitutetStockholmSwedenParticipant
Mattek in Vitro Life Science Laboratories SroBratislavaSlovakiaAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI